US5219837A
(en)
|
1990-06-21 |
1993-06-15 |
Trustees Of The University Of Pennsylvania |
Method of stimulating myelination of cells
|
US5858725A
(en)
|
1990-10-10 |
1999-01-12 |
Glaxo Wellcome Inc. |
Preparation of chimaeric antibodies using the recombinant PCR strategy
|
GB9115364D0
(en)
|
1991-07-16 |
1991-08-28 |
Wellcome Found |
Antibody
|
US5843749A
(en)
|
1991-07-26 |
1998-12-01 |
Regeneron Pharmaceuticals, Inc. |
Ehk and Ror tyrosine kinases
|
US5855885A
(en)
|
1993-01-22 |
1999-01-05 |
Smith; Rodger |
Isolation and production of catalytic antibodies using phage technology
|
US7473423B2
(en)
|
1994-04-29 |
2009-01-06 |
Mayo Foundation For Medical Education And Research |
Human IgM antibodies, and diagnostic and therapeutic uses thereof particularly in the central nervous system
|
DE69535557T2
(de)
|
1994-12-30 |
2008-04-30 |
Planet Biotechnology, Inc., San Diego |
Verfahren zur herstellung von schutzproteine enthaltende immunoglobuline und ihre verwendung
|
EP0833911B1
(en)
|
1995-06-07 |
2004-05-12 |
Ortho Pharmaceutical Corporation |
Cdr-grafted anti-tissue factor antibodies and methods of use thereof
|
US6037454A
(en)
|
1996-11-27 |
2000-03-14 |
Genentech, Inc. |
Humanized anti-CD11a antibodies
|
US6133426A
(en)
|
1997-02-21 |
2000-10-17 |
Genentech, Inc. |
Humanized anti-IL-8 monoclonal antibodies
|
WO1998041541A1
(en)
|
1997-03-19 |
1998-09-24 |
Johns Hopkins University |
Therapeutic uses of grip and grip-related molecules
|
DE69841273D1
(de)
|
1997-11-17 |
2009-12-17 |
Micromet Ag |
Verfahren zur identifikation von bindestellendomänen, die ihre epitopbindefähigkeit beibehalten
|
DK1069185T3
(da)
|
1998-04-03 |
2011-06-27 |
Chugai Pharmaceutical Co Ltd |
Humaniseret antistof mod human vævsfaktor (TF) og fremgangsmåde til at konstruere humaniseret antistof
|
US6605709B1
(en)
|
1999-04-09 |
2003-08-12 |
Genome Therapeutics Corporation |
Nucleic acid and amino acid sequences relating to Proteus mirabilis for diagnostics and therapeutics
|
AU4574501A
(en)
|
2000-03-17 |
2001-10-03 |
Millennium Pharm Inc |
Method of inhibiting stenosis and restenosis
|
MXPA02012434A
(es)
|
2000-06-16 |
2004-09-06 |
Cambridge Antibody Tech |
Anticuerpos que se unen inmunoespecificamente a estimulador de linfocitos ii.
|
US7105348B2
(en)
|
2000-10-31 |
2006-09-12 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
US20050144655A1
(en)
|
2000-10-31 |
2005-06-30 |
Economides Aris N. |
Methods of modifying eukaryotic cells
|
US6596541B2
(en)
|
2000-10-31 |
2003-07-22 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
US6586251B2
(en)
|
2000-10-31 |
2003-07-01 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
US7214786B2
(en)
|
2000-12-14 |
2007-05-08 |
Kovalic David K |
Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement
|
US20140072979A1
(en)
|
2001-01-16 |
2014-03-13 |
Regeneron Pharmaceuticals, Inc. |
Isolating cells expressing secreted proteins
|
US20090137416A1
(en)
|
2001-01-16 |
2009-05-28 |
Regeneron Pharmaceuticals, Inc. |
Isolating Cells Expressing Secreted Proteins
|
IL156910A0
(en)
|
2001-01-16 |
2004-02-08 |
Regeneron Pharma |
Isolating cells expressing secreted proteins
|
US20140072980A1
(en)
|
2001-01-16 |
2014-03-13 |
Regeneron Pharmaceuticals, Inc. |
Isolating cells expressing secreted proteins
|
CA2456121A1
(en)
|
2001-08-03 |
2003-02-20 |
Medical Research Council |
Intracellular antibodies
|
ES2736165T3
(es)
|
2001-08-23 |
2019-12-26 |
Rsr Ltd |
Regiones epítopo de un receptor de tirotropina (TSH), sus usos y anticuerpos para las mismas
|
WO2003040340A2
(en)
|
2001-11-07 |
2003-05-15 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer
|
JP4063769B2
(ja)
|
2001-12-28 |
2008-03-19 |
中外製薬株式会社 |
タンパク質安定化方法
|
ATE444308T1
(de)
|
2002-02-13 |
2009-10-15 |
Ludwig Inst Cancer Res |
Fusionsproteine humanisierter g250-spezifischer antikörper sowie verwendungen davon
|
US7314974B2
(en)
|
2002-02-21 |
2008-01-01 |
Monsanto Technology, Llc |
Expression of microbial proteins in plants for production of plants with improved properties
|
US7193069B2
(en)
|
2002-03-22 |
2007-03-20 |
Research Association For Biotechnology |
Full-length cDNA
|
JP4319979B2
(ja)
|
2002-04-26 |
2009-08-26 |
ジェネンテック・インコーポレーテッド |
タンパク質の非アフィニティ精製
|
IL149820A0
(en)
|
2002-05-23 |
2002-11-10 |
Curetech Ltd |
Humanized immunomodulatory monoclonal antibodies for the treatment of neoplastic disease or immunodeficiency
|
WO2004009805A1
(ja)
|
2002-07-19 |
2004-01-29 |
Japan Science And Technology Agency |
新規抗体酵素生産方法、新規抗体酵素、およびその利用
|
EP2298806A1
(en)
|
2002-10-16 |
2011-03-23 |
Purdue Pharma L.P. |
Antibodies that bind cell-associated CA 125/0722P and methods of use thereof
|
CA2515081A1
(en)
|
2003-02-07 |
2004-08-19 |
Protein Design Labs, Inc. |
Amphiregulin antibodies and their use to treat cancer and psoriasis
|
US7605235B2
(en)
|
2003-05-30 |
2009-10-20 |
Centocor, Inc. |
Anti-tissue factor antibodies and compositions
|
KR20060015602A
(ko)
|
2003-05-31 |
2006-02-17 |
마이크로메트 에이지 |
EpCAM 에 대한 이중 특이성 항체를 포함하는약학조성물
|
US7569389B2
(en)
|
2004-09-30 |
2009-08-04 |
Ceres, Inc. |
Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
|
AU2003271174A1
(en)
|
2003-10-10 |
2005-04-27 |
Chugai Seiyaku Kabushiki Kaisha |
Double specific antibodies substituting for functional protein
|
ATE493441T1
(de)
|
2003-10-16 |
2011-01-15 |
Micromet Ag |
Multispezifische deimmunisierte cd3-bindende moleküle
|
US7612179B2
(en)
|
2003-11-28 |
2009-11-03 |
Astrazeneca Ab |
antibodies binding to a C-terminal fragment of apoliopoprotein E
|
SI2383295T1
(sl)
|
2003-12-10 |
2015-07-31 |
E.R. Squibb & Sons, L.L.C. |
Protitelesa IP-10 in njihova uporaba
|
US8298532B2
(en)
|
2004-01-16 |
2012-10-30 |
Regeneron Pharmaceuticals, Inc. |
Fusion polypeptides capable of activating receptors
|
WO2005070966A2
(en)
|
2004-01-16 |
2005-08-04 |
Regeneron Pharmaceuticals, Inc. |
Fusion polypeptides capable of activating receptors
|
CA2555503C
(en)
|
2004-02-16 |
2018-03-27 |
Micromet Ag |
Humanized anti-cd3 bispecific binding molecules having reduced immunogenicity, uses and compositions relating thereto
|
EP3653641A1
(en)
|
2004-02-19 |
2020-05-20 |
Genentech, Inc. |
Cdr-repaired antibodies
|
US7504086B2
(en)
|
2004-03-31 |
2009-03-17 |
Canon Kabushiki Kaisha |
Structure and method for releasing substance therefrom
|
JP2007532111A
(ja)
|
2004-04-06 |
2007-11-15 |
ザ・レジェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア |
乳癌における標的としてのオーファン受容体チロシンキナーゼ
|
CN101495512A
(zh)
|
2004-04-22 |
2009-07-29 |
弗劳恩农场主协会应用研究开发E.V. |
特异地结合链球菌表面抗原ⅰ/ⅱ的双价抗体及其使用方法
|
US7763249B2
(en)
|
2004-04-27 |
2010-07-27 |
Juridical Foundation The Chemo-Sero-Therapeutic Research Institute |
Human anti-amyloid β peptide antibody and fragment of said antibody
|
MY148646A
(en)
|
2004-05-10 |
2013-05-15 |
Abgenomics Cooperatief Ua |
Anti-psgl-1 antibodies
|
RU2006146939A
(ru)
|
2004-06-09 |
2008-07-20 |
Дженентек |
Способ лечения кольцевидной гранулемы или саркоида
|
BRPI0514478A
(pt)
|
2004-08-16 |
2008-06-17 |
Cropdesign Nv |
método para melhorar caracterìsticas de crescimento de plantas, plantas, construção, método para a produção de uma planta transgênica, planta transgênica, partes coletáveis, e, usos de um ácido nucleico/gene codificando proteìna de ligação de rna ou variante do mesmo ou uso de uma proteìna de ligação de rna ou homólogo da mesma, de um rbp1 ou variante do mesmo ou uso de um polipeptìdeo rbp1 ou homólogo do mesmo e de uma proteìna de ligação de rna ou variante da mesma ou uso de um rbp1 ou variante do mesmo
|
TWI380996B
(zh)
|
2004-09-17 |
2013-01-01 |
Hoffmann La Roche |
抗ox40l抗體
|
AU2005291486A1
(en)
|
2004-10-01 |
2006-04-13 |
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. |
Novel antibodies directed to the mammalian EAG1 ion channel protein
|
CA2591665C
(en)
|
2004-12-20 |
2015-05-05 |
Crucell Holland B.V. |
Binding molecules capable of neutralizing west nile virus and uses thereof
|
PL1848744T3
(pl)
|
2005-01-27 |
2012-06-29 |
Novimmune Sa |
Ludzkie przeciwciała anty-interferon gamma i sposoby ich zastosowania
|
US8088976B2
(en)
|
2005-02-24 |
2012-01-03 |
Monsanto Technology Llc |
Methods for genetic control of plant pest infestation and compositions thereof
|
WO2006106959A1
(ja)
|
2005-03-31 |
2006-10-12 |
Biomedics Inc. |
抗cd20モノクローナル抗体
|
JP5004154B2
(ja)
|
2005-04-06 |
2012-08-22 |
一般財団法人化学及血清療法研究所 |
組換え抗ボツリヌス神経毒素抗体
|
DK1874818T3
(da)
|
2005-04-22 |
2011-06-14 |
Lilly Co Eli |
TGF-Beta 1-specifikke antistoffer
|
US20070124833A1
(en)
|
2005-05-10 |
2007-05-31 |
Abad Mark S |
Genes and uses for plant improvement
|
US7736647B2
(en)
|
2005-06-15 |
2010-06-15 |
Monoclonal Antibodies Therapeutics |
Anti-CD71 monoclonal antibodies and uses thereof for treating malignant tumor cells
|
EP1931710B1
(en)
|
2005-08-31 |
2017-01-18 |
Merck Sharp & Dohme Corp. |
Engineered anti-il-23 antibodies
|
WO2008103849A2
(en)
|
2007-02-21 |
2008-08-28 |
The Regents Of The University Of California |
Methods and compounds for lymphoma cell detection and isolation
|
EP1948680A4
(en)
|
2005-10-28 |
2010-01-13 |
Univ California |
METHOD AND COMPOUNDS FOR DETECTING AND ISOLATING LYMPHOMA CELLS
|
WO2007054816A2
(en)
|
2005-11-14 |
2007-05-18 |
Bioren, Inc. |
Antibody ultrahumanization by predicted mature cdr blasting and cohort library generation and screening
|
EP2548956A1
(en)
|
2006-02-14 |
2013-01-23 |
Verenium Corporation |
Xylanases, nucleic acids encoding them and methods for making and using them
|
JPWO2007102200A1
(ja)
|
2006-03-07 |
2009-07-23 |
国立大学法人大阪大学 |
抗cd20モノクローナル抗体
|
WO2007146957A2
(en)
|
2006-06-13 |
2007-12-21 |
Irm Llc |
Ror1 as a therapeutic target for lung cancer
|
AU2007284651B2
(en)
|
2006-08-09 |
2014-03-20 |
Institute For Systems Biology |
Organ-specific proteins and methods of their use
|
TWI454480B
(zh)
|
2006-08-18 |
2014-10-01 |
Novartis Ag |
催乳激素受體(prlr)之專一性抗體及其用途
|
PL2066694T3
(pl)
|
2006-09-29 |
2016-04-29 |
Oncomed Pharm Inc |
Kompozycje i sposoby diagnozowania i leczenia nowotworu
|
WO2008066691A2
(en)
|
2006-11-08 |
2008-06-05 |
Macrogenics West, Inc. |
Tes7 and antibodies that bind thereto
|
FR2909092B1
(fr)
|
2006-11-24 |
2012-10-19 |
Pf Medicament |
Nouveaux anticorps anti-proliferation
|
WO2008076868A2
(en)
|
2006-12-18 |
2008-06-26 |
Abbott Laboratories |
Methods and compositions related to modulation of receptor tyrosine kinase orphan receptor-1 (ror-1)
|
AR064610A1
(es)
|
2006-12-22 |
2009-04-15 |
Schering Corp |
Anticuerpos contra el cd200r
|
WO2008097439A2
(en)
|
2007-02-07 |
2008-08-14 |
The Trustees Of The University Of Pennsylvania |
Anti-autoimmune antibodies for treatment of pemphigus
|
US9745367B2
(en)
|
2007-03-23 |
2017-08-29 |
Novelmed Theraputics, Inc. |
Alternative pathway specific antibodies for treating arthritis
|
WO2008127735A1
(en)
|
2007-04-13 |
2008-10-23 |
Stemline Therapeutics, Inc. |
Il3ralpha antibody conjugates and uses thereof
|
US20100129817A1
(en)
|
2007-05-03 |
2010-05-27 |
Regeneron Pharmaceuticals Inc. |
Identifying germline competent embryonic stem cells
|
EP2158215B1
(en)
|
2007-05-17 |
2015-04-22 |
Genentech, Inc. |
Crystal structures of neuropilin fragments and neuropilin-antibody complexes
|
AU2008272330A1
(en)
|
2007-07-04 |
2009-01-08 |
Forerunner Pharma Research Co., Ltd. |
Anti-Muc17 antibody
|
US8299318B2
(en)
|
2007-07-05 |
2012-10-30 |
Ceres, Inc. |
Nucleotide sequences and corresponding polypeptides conferring modulated plant characteristics
|
CA2694396A1
(en)
|
2007-07-25 |
2009-01-29 |
Astrazeneca Ab |
Targeted binding agents directed to kdr and uses thereof - 035
|
JPWO2009031230A1
(ja)
|
2007-09-06 |
2010-12-09 |
国立大学法人大阪大学 |
抗cd20モノクローナル抗体
|
US8362325B2
(en)
|
2007-10-03 |
2013-01-29 |
Ceres, Inc. |
Nucleotide sequences and corresponding polypeptides conferring modulated plant characteristics
|
KR101658083B1
(ko)
|
2007-10-19 |
2016-09-30 |
시애틀 지네틱스, 인크. |
씨디19 결합제 및 그의 용도
|
EP2220247A4
(en)
|
2007-11-16 |
2011-10-26 |
Nuvelo Inc |
ANTIBODIES DIRECTED AGAINST LRP6
|
BRPI0821110B8
(pt)
|
2007-12-05 |
2021-05-25 |
Chugai Pharmaceutical Co Ltd |
anticorpo de neutralização de anti-nr10/il31ra, composição farmacêutica compreendendo o referido anticorpo e uso do mesmo
|
PT2242771E
(pt)
|
2007-12-14 |
2013-08-29 |
Bristol Myers Squibb Co |
Moléculas de ligação ao recetor humano ox40
|
EP2231186A4
(en)
|
2007-12-17 |
2012-08-08 |
Dyax Corp |
COMPOSITIONS AND METHODS FOR TREATING OSTEOLYTIC DISORDERS COMPRISING MMP-14 BINDING PROTEINS
|
AU2008343855B2
(en)
|
2007-12-21 |
2013-08-15 |
Amgen Inc. |
Anti-amyloid antibodies and uses thereof
|
CA2710680C
(en)
|
2007-12-26 |
2018-10-16 |
Vaccinex, Inc. |
Anti-c35 antibody combination therapies and methods
|
WO2009097128A1
(en)
|
2008-01-29 |
2009-08-06 |
Ludwig Institute For Cancer Research Ltd. |
Membrane transporter napi2b (slc34a2) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy
|
WO2009099580A2
(en)
|
2008-02-05 |
2009-08-13 |
Monsanto Technology, Llc |
Isolated novel nucleic acid and protein molecules from soy and methods of using those molecules to generate transgenic plants with enhanced agronomic traits
|
AR070316A1
(es)
|
2008-02-07 |
2010-03-31 |
Merck & Co Inc |
Antagonistas de pcsk9 (proproteina subtilisina-kexina tipo 9)
|
CA2715166C
(en)
|
2008-02-11 |
2017-05-16 |
Curetech Ltd. |
Monoclonal antibodies for tumor treatment
|
JP2011517662A
(ja)
|
2008-03-03 |
2011-06-16 |
ダイアックス コーポレーション |
メタロプロテアーゼ9結合タンパク質
|
EP2262837A4
(en)
|
2008-03-12 |
2011-04-06 |
Merck Sharp & Dohme |
PD-1 BINDING PROTEINS
|
WO2009126659A1
(en)
|
2008-04-07 |
2009-10-15 |
Kalobios Pharmaceuticals, Inc. |
Neutralization of gm-csf for the treatment of heart failure
|
US8314213B2
(en)
|
2008-04-18 |
2012-11-20 |
Xencor, Inc. |
Human equivalent monoclonal antibodies engineered from nonhuman variable regions
|
BRPI0910482A2
(pt)
|
2008-04-29 |
2019-09-24 |
Abbott Lab |
imunoglobinas de domínio variável duplo e usos das mesmas
|
WO2009154026A1
(ja)
|
2008-06-20 |
2009-12-23 |
国立大学法人岡山大学 |
石灰化小球に対する抗体及びその用途
|
EP2313435A4
(en)
|
2008-07-01 |
2012-08-08 |
Aveo Pharmaceuticals Inc |
FIBROBLAST GROWTH FACTOR RECEPTOR 3 (FGFR3) BINDING PROTEINS
|
US8632774B2
(en)
|
2008-07-02 |
2014-01-21 |
Emergent Product Development Seattle, Llc |
Antagonists of IL-6
|
CN106924729B
(zh)
|
2008-07-16 |
2021-03-02 |
生物医学研究学会 |
人巨细胞病毒中和抗体及其应用
|
JP5841332B2
(ja)
|
2008-07-18 |
2016-01-13 |
国立大学法人名古屋大学 |
細胞増殖阻害剤
|
CA2731038A1
(en)
|
2008-07-31 |
2010-02-04 |
Basf Plant Science Gmbh |
Plants having modified growth characteristics and a method for making the same
|
CN102264391A
(zh)
|
2008-08-20 |
2011-11-30 |
森托科尔奥索生物科技公司 |
工程化抗il-13抗体、组合物、方法和用途
|
CN102245773B
(zh)
|
2008-11-03 |
2014-08-27 |
阿莱斯亚生物疗法股份有限公司 |
特异性地阻滞肿瘤抗原的生物活性的抗体
|
US8183346B2
(en)
|
2008-12-05 |
2012-05-22 |
Eli Lilly And Company |
Anti-ferroportin 1 monoclonal antibodies and uses thereof
|
WO2010083179A2
(en)
|
2009-01-16 |
2010-07-22 |
Monsanto Technology Llc |
Isolated novel nucleic acid and protein molecules from soybeans and methods of using those molecules to generate transgenic plants with enhanced agronomic traits
|
US8673307B1
(en)
|
2009-03-09 |
2014-03-18 |
The Rockefeller University |
HIV-1 anti-core neutralizing antibodies that target a conformational epitope within the ALPHA5-helix of GP120
|
AU2010226814B2
(en)
|
2009-03-20 |
2013-05-16 |
Amgen Inc. |
Alpha-4-beta-7 heterodimer specific antagonist antibody
|
US8524869B2
(en)
|
2009-03-24 |
2013-09-03 |
Teva Biopharmaceuticals Usa, Inc. |
Humanized antibodies against LIGHT and uses thereof
|
UA104459C2
(uk)
|
2009-03-25 |
2014-02-10 |
Дженентек, Інк. |
Антитіла проти fgfr3 і способи їх застосування
|
WO2010117455A2
(en)
|
2009-04-08 |
2010-10-14 |
U.S. Army Medical Research Institute Of Infectious Diseases |
Human monoclonal antibodies protective against bubonic plaque
|
ES2641612T3
(es)
|
2009-04-17 |
2017-11-10 |
Immunas Pharma, Inc. |
Anticuerpos que se unen específicamente a oligómeros de beta A y uso de los mismos
|
CA2759733C
(en)
|
2009-04-23 |
2019-09-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-human ror1 antibodies
|
WO2010129304A2
(en)
|
2009-04-27 |
2010-11-11 |
Oncomed Pharmaceuticals, Inc. |
Method for making heteromultimeric molecules
|
BR112012003064B8
(pt)
|
2009-08-13 |
2021-05-25 |
Crucell Holland Bv |
anticorpo ou fragmento de ligação de antígeno do mesmo, combinação que os compreende, método de detecção de infecção por rsv, moléculas de ácido nucléico, e método de produção de um anticorpo ou fragmento de ligação de antígeno do mesmo
|
PT2470671E
(pt)
|
2009-08-28 |
2015-02-05 |
Regeneron Pharma |
Anticorpos anticinas que se ligam a múltiplas quimiocinas
|
WO2011038290A2
(en)
|
2009-09-25 |
2011-03-31 |
The U. S. A., As Represented By The Secretary, Department Of Health And Human Services |
Neutralizing antibodies to hiv-1 and their use
|
US8926976B2
(en)
|
2009-09-25 |
2015-01-06 |
Xoma Technology Ltd. |
Modulators
|
JP2013508287A
(ja)
|
2009-10-14 |
2013-03-07 |
ヤンセン バイオテツク,インコーポレーテツド |
抗体を親和性成熟する方法
|
CN102596996B
(zh)
|
2009-10-30 |
2014-06-18 |
东丽株式会社 |
对丙型肝炎病毒(hcv)具有感染抑制活性的抗体及其用途
|
US20120282177A1
(en)
|
2009-11-02 |
2012-11-08 |
Christian Rohlff |
ROR1 as Therapeutic and Diagnostic Target
|
EP3305813B1
(en)
|
2009-11-11 |
2020-01-15 |
Ganymed Pharmaceuticals GmbH |
Antibodies specific for claudin 6 (cldn6)
|
WO2011084496A1
(en)
|
2009-12-16 |
2011-07-14 |
Abbott Biotherapeutics Corp. |
Anti-her2 antibodies and their uses
|
US9150647B2
(en)
|
2009-12-18 |
2015-10-06 |
Kancera Ab |
Biological inhibitors of ROR1 capable of inducing cell death
|
JP6034696B2
(ja)
|
2010-02-12 |
2016-11-30 |
オンコメッド ファーマシューティカルズ インコーポレイテッド |
ポリペプチド発現細胞の同定及び単離の方法
|
US8609095B2
(en)
|
2010-03-04 |
2013-12-17 |
Symphogen A/S |
Anti-HER2 antibodies and compositions
|
JP6039428B2
(ja)
|
2010-03-04 |
2016-12-07 |
シムフォゲン・アクティーゼルスカブSymphogen A/S |
抗her2抗体および組成物
|
CA2789071C
(en)
|
2010-03-05 |
2018-03-27 |
F. Hoffmann-La Roche Ag |
Antibodies against human csf-1r and uses thereof
|
US8468130B2
(en)
|
2010-04-02 |
2013-06-18 |
Skyfire Labs, Inc. |
Assisted hybrid mobile browser
|
US9073990B2
(en)
|
2010-04-05 |
2015-07-07 |
Bar-Llan University |
Protease-activatable pore-forming polypeptides
|
EP2572203B1
(en)
|
2010-05-17 |
2017-10-25 |
The Board of Regents of The University of Texas System |
Determination of antigen-specific antibody sequences in blood circulation
|
AR081434A1
(es)
|
2010-06-10 |
2012-08-29 |
Lilly Co Eli |
Anticuerpo del peptido relacionado con el gen calcitonina (cgrp), composicion farmaceutica que lo comprende, uso de dicho anticuerpo para preparar un medicamento util para tratar dolor de osteoartritis o migranas y fragmento de union a antigeno de dicho anticuerpo
|
JP2012021943A
(ja)
|
2010-07-16 |
2012-02-02 |
National Cancer Center |
子宮体がんの検査方法、子宮体がんの検査薬、並びに子宮体がん抗原に対する抗体
|
US9163258B2
(en)
|
2010-07-23 |
2015-10-20 |
Fred Hutchinson Cancer Research Center |
Method for the treatment of obesity
|
JP2013542188A
(ja)
|
2010-09-22 |
2013-11-21 |
ノヴォ ノルディスク アー/エス |
治療用第viii因子抗体
|
EP3828205A1
(en)
|
2010-10-01 |
2021-06-02 |
Oxford BioTherapeutics Ltd |
Anti-ror1 antibodies
|
SG189929A1
(en)
|
2010-10-29 |
2013-06-28 |
Immunogen Inc |
Novel egfr-binding molecules and immunoconjugates thereof
|
JO3756B1
(ar)
|
2010-11-23 |
2021-01-31 |
Regeneron Pharma |
اجسام مضادة بشرية لمستقبلات الجلوكاجون
|
EP2455403A1
(en)
|
2010-11-23 |
2012-05-23 |
Pierre Fabre Medicament |
Homogeneous humanized antibodies against JAM-A that inhibit proliferation
|
EP2646469B1
(en)
|
2010-12-01 |
2017-11-01 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Chimeric rabbit/human ror1 antibodies
|
GB201020995D0
(en)
|
2010-12-10 |
2011-01-26 |
Bioinvent Int Ab |
Biological materials and uses thereof
|
US8816055B2
(en)
|
2011-01-06 |
2014-08-26 |
Dyax Corp. |
Plasma kallikrein binding proteins
|
CA3027071A1
(en)
|
2011-01-14 |
2013-07-19 |
The Regents Of The University Of California |
Therapeutic antibodies against ror-1 protein and methods for use of same
|
BR112013020743A2
(pt)
|
2011-02-14 |
2016-10-18 |
Theraclone Sciences Inc |
composições e métodos para a terapia e diagnóstico de influenza
|
US8906635B2
(en)
|
2011-02-28 |
2014-12-09 |
Northshore University Healthsystem |
Methods of diagnosing Clostridium difficile infection
|
BR112013027229B1
(pt)
|
2011-04-22 |
2020-10-27 |
Wyeth Llc |
polipeptídeo imunogênico isolado e seu uso, composição imunogênica e seu uso, célula recombinante ou progênie da mesma, e método de produção de uma toxina de clostridium difficile mutante
|
ES2565063T3
(es)
|
2011-05-13 |
2016-03-31 |
Ganymed Pharmaceuticals Ag |
Anticuerpos para el tratamiento de un cáncer que expresa la claudina 6
|
WO2013019730A1
(en)
|
2011-07-29 |
2013-02-07 |
The Washington University |
Antibodies to tip-1 and grp78
|
EP3783028A1
(en)
|
2011-08-12 |
2021-02-24 |
Omeros Corporation |
Anti-fzd10 monoclonal antibodies and methods for their use
|
PL2758073T3
(pl)
|
2011-09-23 |
2019-04-30 |
Oncomed Pharm Inc |
Środki wiążące VEGF/DLL4 i ich zastosowania
|
AU2012322093C1
(en)
|
2011-10-13 |
2016-12-22 |
Bristol-Myers Squibb Company |
Antibody polypeptides that antagonize CD40L
|
MX361772B
(es)
*
|
2011-10-19 |
2018-12-17 |
Pharmacyclics Llc |
Uso de inhibidores de la tirosina cinasa de bruton (btk).
|
EP2589609A1
(en)
|
2011-11-03 |
2013-05-08 |
Pierre Fabre Medicament |
Antigen binding protein and its use as addressing product for the treatment of cancer
|
US20130131139A1
(en)
*
|
2011-11-17 |
2013-05-23 |
Oregon Health & Science University |
Ror1 as a gene target in acute lymphoblastic leukemia
|
EP2617319A1
(en)
|
2012-01-17 |
2013-07-24 |
Braun GmbH |
Head portion and handle portion of an oral care device
|
CA2864869C
(en)
|
2012-02-21 |
2021-10-19 |
Toray Industries, Inc. |
Pharmaceutical composition for treatment and/or prevention of cancer
|
MX360208B
(es)
|
2012-02-21 |
2018-10-24 |
Toray Industries |
Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
|
AU2013203459B2
(en)
|
2012-02-24 |
2016-11-03 |
Abbvie Stemcentrx Llc |
DLL3 modulators and methods of use
|
JP6280031B2
(ja)
|
2012-03-29 |
2018-02-14 |
中外製薬株式会社 |
抗lamp5抗体およびその利用
|
ES2656620T3
(es)
|
2012-03-30 |
2018-02-27 |
Toray Industries, Inc. |
Composición farmacéutica para el tratamiento y/o la prevención del cáncer de hígado
|
PT2832366T
(pt)
|
2012-03-30 |
2018-01-25 |
Toray Industries |
Composição farmacêutica para o tratamento e/ou a prevenção de cancro de vesícula biliar
|
CN104220454B
(zh)
|
2012-04-03 |
2018-09-07 |
诺沃姆德治疗公司 |
人源化的嵌合抗因子Bb抗体及其用途
|
AU2013256596A1
(en)
|
2012-05-01 |
2014-10-09 |
Genentech, Inc. |
Anti-PMEL17 antibodies and immunoconjugates
|
KR20150013277A
(ko)
|
2012-05-14 |
2015-02-04 |
제넨테크, 인크. |
종양의 진단 및 치료를 위한 조성물 및 방법
|
CN103421113B
(zh)
|
2012-05-22 |
2018-01-19 |
武汉华鑫康源生物医药有限公司 |
抗BLyS抗体
|
JO3462B1
(ar)
|
2012-08-22 |
2020-07-05 |
Regeneron Pharma |
أجسام مضادة بشرية تجاه gfr?3 وطرق لاستخدامها
|
EP3489261B1
(en)
|
2012-08-24 |
2020-10-21 |
The Regents of The University of California |
Antibodies and vaccines for use in treating ror1 cancers and inhibiting metastasis
|
CN103792364B
(zh)
|
2012-10-31 |
2016-06-08 |
张宝弘 |
用于检测外周血中循环肿瘤细胞ror1蛋白的试剂及其应用
|
TWI675044B
(zh)
|
2012-11-14 |
2019-10-21 |
美商再生元醫藥公司 |
重組細胞表面捕捉蛋白質
|
TWI670081B
(zh)
|
2013-02-22 |
2019-09-01 |
美商艾伯維史坦森特瑞斯有限責任公司 |
新穎抗體結合物及其用途
|
EP2789630A1
(en)
|
2013-04-09 |
2014-10-15 |
EngMab AG |
Bispecific antibodies against CD3e and ROR1
|
WO2014174111A1
(en)
|
2013-04-26 |
2014-10-30 |
Pierre Fabre Medicament |
Axl antibody-drug conjugate and its use for the treatment of cancer
|
HUE065593T2
(hu)
|
2013-05-20 |
2024-06-28 |
Hoffmann La Roche |
Anti-transzferrin receptor antitestek és alkalmazási eljárások
|
WO2015014376A1
(en)
|
2013-07-31 |
2015-02-05 |
Biontech Ag |
Diagnosis and therapy of cancer involving cancer stem cells
|
AU2014312210A1
(en)
|
2013-08-28 |
2016-04-07 |
Abbvie Stemcentrx Llc |
Engineered anti-DLL3 conjugates and methods of use
|
RU2016122041A
(ru)
|
2013-11-06 |
2017-12-11 |
ЭББВИ СТЕМСЕНТРКС ЭлЭлСи |
Новые анти-клаудин антитела и способы их применения
|
AU2014360811B2
(en)
|
2013-12-11 |
2017-05-18 |
Regeneron Pharmaceuticals, Inc. |
Methods and compositions for the targeted modification of a genome
|
EA201691214A1
(ru)
|
2013-12-13 |
2016-12-30 |
Дженентек, Инк. |
Антитела к cd33 и иммуноконъюгаты
|
NZ721309A
(en)
|
2013-12-17 |
2019-11-29 |
Genentech Inc |
Anti-cd3 antibodies and methods of use
|
EP3086809A4
(en)
|
2013-12-24 |
2017-11-29 |
NovelMed Therapeutics, Inc. |
Compositions and methods of treating ocular diseases
|
EA201691683A1
(ru)
|
2014-02-21 |
2017-04-28 |
ЭББВИ СТЕМСЕНТРКС ЭлЭлСи |
Антитела против dll3 и конъюгаты антитело-лекарственное средство для применения при меланоме
|
CN106459165B
(zh)
|
2014-04-01 |
2021-04-20 |
拜恩科技细胞&基因治疗有限公司 |
密封蛋白-6特异性免疫受体和t细胞表位
|
LT3888674T
(lt)
|
2014-04-07 |
2024-07-25 |
Novartis Ag |
Vėžio gydymas naudojant anti-cd19 chimerinį antigeno receptorių
|
BR112016024363A2
(pt)
|
2014-04-25 |
2017-10-10 |
Pf Medicament |
conjugado de anticorpo-fármaco e seu uso para tratamento de câncer
|
SG11201811559WA
(en)
|
2016-06-27 |
2019-01-30 |
Univ California |
Cancer treatment combinations
|
WO2018237335A1
(en)
*
|
2017-06-23 |
2018-12-27 |
VelosBio Inc. |
IMMUNOCONJUGUATED ROR1 ANTIBODIES
|